{"id":18572,"date":"2021-07-30T07:16:08","date_gmt":"2021-07-30T11:16:08","guid":{"rendered":"https:\/\/medicarereport.org\/?p=18572"},"modified":"2021-07-30T07:53:29","modified_gmt":"2021-07-30T11:53:29","slug":"diabetes-drugs-new-weight-loss-formula-fuels-cost-benefit-debate","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=18572","title":{"rendered":"Diabetes Drug\u2019s New Weight Loss Formula Fuels Cost-Benefit Debate"},"content":{"rendered":"

(By Julie Appleby for Kaiser Health News)<\/p>\n

The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people \u2014 especially those with Type 2 diabetes, which is associated with obesity \u2014 may desperately want.<\/p>\n

So it\u2019s no surprise that some of the same drugs are being reformulated and renamed by manufacturers as a new obesity treatment. No longer limited to the crowded field of treatments for Type 2 diabetes, which affects about 10% of Americans, they join the far smaller number of drugs for obesity, which affects 42% of Americans and is ready to be mined for profit.\u00a0 Continue reading the article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation<\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Julie Appleby for Kaiser Health News) The long list of side effects that follow ads for the newer expensive<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42,12,15],"tags":[],"class_list":["post-18572","post","type-post","status-publish","format-standard","hentry","category-employer-healthcare","category-health-care-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18572"}],"version-history":[{"count":2,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18572\/revisions"}],"predecessor-version":[{"id":18576,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18572\/revisions\/18576"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}